SEVEN EIGHT CAPITAL, LP - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 171 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
SEVEN EIGHT CAPITAL, LP ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$721,0000.0%46,6000.0%0.17%
+1.2%
Q4 2020$721,000
-36.4%
46,600
-39.9%
0.16%
-33.1%
Q3 2020$1,133,000
+143.1%
77,600
+219.3%
0.24%
+880.0%
Q4 2019$466,00024,3000.02%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders